These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1652256)

  • 21. Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts.
    Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
    Anticancer Drug Des; 1995 Jan; 10(1):97-102. PubMed ID: 7695815
    [No Abstract]   [Full Text] [Related]  

  • 22. Protein expression and preliminary crystallographic analysis of amino-terminal fragment of urokinase-type plasminogen activator.
    Zhao G; Yuan C; Bian C; Hou X; Shi X; Ye X; Huang Z; Huang M
    Protein Expr Purif; 2006 Sep; 49(1):71-7. PubMed ID: 16806969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme systems. Better reception for urokinase.
    Mangel WF
    Nature; 1990 Apr; 344(6266):488-9. PubMed ID: 2157162
    [No Abstract]   [Full Text] [Related]  

  • 24. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
    Behrendt N; Ploug M; Patthy L; Houen G; Blasi F; Danø K
    J Biol Chem; 1991 Apr; 266(12):7842-7. PubMed ID: 1850423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
    Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domain structure and interactions of plasminogen activators.
    Medved LV; Novokhatny VV; Ingham KC
    Ukr Biokhim Zh (1978); 1996; 68(4):39-40. PubMed ID: 9226825
    [No Abstract]   [Full Text] [Related]  

  • 28. Urokinase-type plasminogen activator.
    Crippa MP
    Int J Biochem Cell Biol; 2007; 39(4):690-4. PubMed ID: 17118695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.
    Kamiyama H; Zhou G; Roizman B
    Gene Ther; 2006 Apr; 13(7):621-9. PubMed ID: 16292350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis.
    Beal MF
    Exp Neurol; 2008 Jun; 211(2):332-3. PubMed ID: 18423450
    [No Abstract]   [Full Text] [Related]  

  • 32. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
    Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
    Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen-receptor
    Flick MJ; Bugge TH
    J Thromb Haemost; 2017 Jan; 15(1):150-154. PubMed ID: 27740735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family.
    Wang Y; Dang J; Johnson LK; Selhamer JJ; Doe WF
    Eur J Biochem; 1995 Jan; 227(1-2):116-22. PubMed ID: 7531640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of the urokinase-type plasminogen activator receptor gene.
    Casey JR; Petranka JG; Kottra J; Fleenor DE; Rosse WF
    Blood; 1994 Aug; 84(4):1151-6. PubMed ID: 8049431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human neuromodulator SLURP-1: bacterial expression, binding to muscle-type nicotinic acetylcholine receptor, secondary structure, and conformational heterogeneity in solution.
    Shulepko MA; Lyukmanova EN; Paramonov AS; Lobas AA; Shenkarev ZO; Kasheverov IE; Dolgikh DA; Tsetlin VI; Arseniev AS; Kirpichnikov MP
    Biochemistry (Mosc); 2013 Feb; 78(2):204-11. PubMed ID: 23581991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel urokinase receptor on monocyte-like macrophage cell line.
    Bayraktutan U; Jones P
    Biochem Soc Trans; 1993 Nov; 21(4):395S. PubMed ID: 8131971
    [No Abstract]   [Full Text] [Related]  

  • 39. Two PstI polymorphisms for the urokinase-type plasminogen activator receptor gene (PLAUR).
    Børglum AD; Byskov A; Roldan AL; Kruse TA
    Hum Genet; 1992 Jul; 89(5):584. PubMed ID: 1353059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.
    Adeyo O; Oberer M; Ploug M; Fong LG; Young SG; Beigneux AP
    Br J Dermatol; 2015 Oct; 173(4):1066-9. PubMed ID: 25919322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.